Low socioeconomic status, adverse gene expression profiles, and clinical outcomes in hematopoietic stem cell transplant recipients

Clinical Cancer Research

Volumn 22, Issue 1, 2016, Pages 69-78

  Knight, Jennifer M ^a   Rizzo, J Douglas ^a   Logan, Brent R ^a   Wang, Tao ^a   Arevalo, Jesusa M G ^b   Ma, Jeffrey ^b   Cole, Steve W ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; INTERFERON; TRANSCRIPTOME;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ADVERSE OUTCOME; ANTIBODY PRODUCTION; ARTICLE; BIOINFORMATICS; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CTRA GENE; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MIDDLE AGED; ONCOGENE; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; SOCIAL ENVIRONMENT; SOCIAL STATUS; TRANSCRIPTION INITIATION; TRANSCRIPTOMICS; UNRELATED DONORS; UPREGULATION; YOUNG ADULT; CAUSE OF DEATH; COMORBIDITY; DONOR; GENETICS; MALE; METABOLISM; MONONUCLEAR CELL; MORTALITY; NEOPLASMS; PROGNOSIS; REGISTER; RISK FACTOR; SOCIAL CLASS;

ADULT; CAUSE OF DEATH; COMORBIDITY; FEMALE; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEOPLASMS; PATIENT OUTCOME ASSESSMENT; PROGNOSIS; REGISTRIES; RISK FACTORS; SOCIAL CLASS; TISSUE DONORS; TRANSCRIPTOME; YOUNG ADULT;

EID: 84954345425     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-15-1344     Document Type: Article

References (49)

1. Baker KS, Davies SM, Majhail NS, Hassebroek A, Klein JP, Ballen KK, et al. Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant 2009; 15:1543-54.
2. Silla L, Fischer GB, Paz A, Daudt LE, Mitto I, Katz B, et al. Patient socioeconomic status as a prognostic factor for allo-SCT. Bone Marrow Transplant 2009;43:571-7.
3. Aziz Z, Iqbal J, Akram M, Anderson BO. Worsened oncologic outcomes for women of lower socio-economic status (SES) treated for locally advanced breast cancer (LABC) in pakistan. Breast 2010;19:38-43.
4. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: Selected findings from the surveillance, epidemiology, and end results: National longitudinal mortality study. Cancer Causes Control 2009;20: 417-35.
5. Owen N, Poulton T, Hay FC, Mohamed-Ali V, Steptoe A. Socioeconomic status, C-reactive protein, immune factors, and responses to acute mental stress. Brain Behav Immun 2003;17:286-95.
6. Williams DR. Socioeconomic differentials in health: A review and redirection. Soc Psychol Q 1990:81-99.
7. Miller GE, Chen E, Fok AK, Walker H, Lim A, Nicholls EF, et al. Low earlylife social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc Natl Acad Sci U S A 2009;106:14716-21.
8. Black PH. The inflammatory consequences of psychologic stress: Relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med Hypotheses 2006;67:879-91.
9. Gruenewald TL, Cohen S, Matthews KA, Tracy R, Seeman TE. Association of socioeconomic status with inflammation markers in black and white men and women in the coronary artery risk development in young adults (CARDIA) study. Soc Sci Med 2009;69:451-9.
10. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol 2004;5:617-25.
11. Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, McDonald PG, et al. The influence of bio-behavioural factors on tumour biology: Pathways and mechanisms. Nat Rev Cancer 2006;6:240-8.
12. Knight JM, Moynihan JA, Lyness JM, Xia Y, Tu X, Messing S, et al. Peritransplant psychosocial factors and neutrophil recovery following hematopoietic stem cell transplantation. PLoS ONE 2014;9:e99778.
13. Cole SW. Nervous system regulation of the cancer genome. Brain Behav Immun 2013;30:S10-8.
14. Knight JM, Lyness JM, Sahler OJZ, Liesveld JL, Moynihan JA. Psychosocial factors and hematopoietic stem cell transplantation: Potential biobehavioral pathways. Psychoneuroendocrinology 2013;38:2383-93.
15. Costanzo ES, Juckett MB, Coe CL. Biobehavioral influences on recovery following hematopoietic stem cell transplantation. Brain Behav Immun 2012;30:S68-S74.
16. Powell ND, Sloan EK, Bailey MT, Arevalo JM, Miller GE, Chen E, et al. Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via beta-adrenergic induction of myelopoiesis. Proc Natl Acad Sci U S A 2013;110:16574-9.
17. Irwin MR, Cole SW. Reciprocal regulation of the neural and innate immune systems. Nat Rev Immunol 2011;11:625-32.
18. Cole SW, Hawkley LC, Arevalo JM, Sung CY, Rose RM, Cacioppo JT. Social regulation of gene expression in human leukocytes. Genome Biol 2007;8: R189.
19. Cacioppo JT, Hawkley LC. Social isolation and health, with an emphasis on underlying mechanisms. Perspect Biol Med 2003;46(3 Suppl):S39-52.
20. Antoni M, Lutgendorf S, Blomberg B, Stagl J, Carver C, Lechner S, et al. Transcriptional modulation of human leukocytes by cognitive-behavioral stress management in women undergoing treatment for breast cancer. Biol Psychiatry 2012;71:366-72.
21. Cole SW, Conti G, Arevalo JM, Ruggiero AM, Heckman JJ, Suomi SJ. Transcriptional modulation of the developing immune system by early life social adversity. Proc Natl Acad Sci U S A 2012;109:20578-83.
22. Tanaka J, Imamura M, Kasai M, Hashino S, Kobayashi S, Noto S, et al. The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease. Bone Marrow Transplant 1997;19:571-6.
23. Nagler A, Or R, Nisman B, Kalickman I, Slavin S, Barak V. Elevated inflammatory cytokine levels in bone marrow graft rejection. Transplantation 1995;60:943-8.
24. Fietze E, Prösch S, Reinke P, Stein J, Döcke WD, Staffa G, et al. Cytomegalovirus infection in transplant recipients. the role of tumor necrosis factor. Transplantation 1994;58:675.
25. Wang XS, Shi Q, Williams LA, Cleeland CS, Mobley GM, Reuben JM, et al. Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer 2008;113:2102-9.
26. Karimi MH, Daneshmandi S, Pourfathollah AA, Geramizadeh B, Ramzi M, Yaghobi R, et al. The IFN-gamma allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplant. Exp Clin Transplant 2010;8:125-9.
27. Lim SH, Coleman S, Bull A, O'Callaghan U, Evely R, Booth M. Cyclosporin A/alpha interferon-induced autologous graft-versus-host disease following peripheral blood stem cell transplant for chronic myeloid leukaemia: A clinico-pathological study. Bone Marrow Transplant 1997;20:83-5.
28. Zip code database-deluxe database specifications. [homepage on the Internet].
29. Ho D, Imai K, King G, Stuart E. Matchit: Nonparametric preprocessing for parametric causal inference. R package version 2006;2:2-11.
30. Jung SH. Sample size for FDR-control in microarray data analysis. Bioinformatics 2005;21:3097-104.
31. Miller GE, Chen E, Sze J, Marin T, Arevalo JMG, Doll R, et al. A functional genomic fingerprint of chronic stress in humans: Blunted glucocorticoid and increased NF-[kappa] B signaling. Biol Psychiatry 2008;64:266-72.
32. Cole SW, Hawkley LC, Arevalo JMG, Cacioppo JT. Transcript origin analysis identifies antigen-presenting cells as primary targets of socially regulated gene expression in leukocytes. Proc Natl Acad Sci U S A 2011;108:3080.
33. Fredrickson BL, Grewen KM, Coffey KA, Algoe SB, Firestine AM, Arevalo JM, et al. A functional genomic perspective on human well-being. Proc Natl Acad Sci U S A 2013;110:13684-9.
34. Efron B, Tibshirani RJ. An introduction to the bootstrap. CRC press; 1994.
35. Cole SW, Yan W, Galic Z, Arevalo J, Zack JA. Expression-based monitoring of transcription factor activity: The TELiS database. Bioinformatics 2005;21:803-10.
36. Cole SW. Elevating the perspective on human stress genomics. Psychoneuroendocrinology 2010;35:955-62.
37. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991;28:250-9.
38. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995;15:825-8.
39. Cole SW, Sood AK. Molecular pathways: Beta-adrenergic signaling in cancer. Clin Cancer Res 2012;18:1201-6.
40. Aydiner A, Ciftci R, Karabulut S, Kilic L. Does beta-blocker therapy improve the survival of patients with metastatic non-small cell lung cancer?. Asian Pac J Cancer Prev 2013;14:6109-14.
41. Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K. Beta blockers and breast cancer mortality: A population-based study. J Clin Oncol 2011;29:2635-44.
42. De Giorgi V, Grazzini M, Gandini S, Benemei S, Lotti T, Marchionni N, et al. Treatment with beta-blockers and reduced disease progression in patients with thick melanoma. Arch Intern Med 2011;171:779-81.
43. Benish M, Bartal I, Goldfarb Y, Levi B, Avraham R, Raz A, et al. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol 2008; 15:2042-52.
44. Lin X, Luo K, Lv Z, Huang J. Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice. Hepatogastroenterology 2012;59:584-8.
45. Lamkin DM, Sloan EK, Patel AJ, Chiang BS, Pimentel MA, Ma JCY, et al. Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling. Brain Behav Immun 2012;26:635-41.
46. Cole SW. Social regulation of human gene expression: Mechanisms and implications for public health. Am J Public Health 2013;103(S1):S84-92.
47. Neeman E, Zmora O, Ben-Eliyahu S. A new approach to reducing postsurgical cancer recurrence: Perioperative targeting of catecholamines and prostaglandins. Clin Cancer Res 2012;18:4895-902.
48. Marks DI, Ballen K, Logan BR, Wang Z, Sobocinski KA, Bacigalupo A, et al. The effect of smoking on allogeneic transplant outcomes. Biology of Blood and Marrow Transplantation 2009;15:1277-87.
49. Chuang YC, Cubbin C, Ahn D, Winkleby MA. Effects of neighbourhood socioeconomic status and convenience store concentration on individual level smoking. J Epidemiol Community Health 2005;59:568-73.